Inflarx Nv Stock Investor Sentiment

IFRX Stock  USD 1.19  0.04  3.48%   
Slightly above 55% of InflaRx NV's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding InflaRx NV suggests that some traders are interested. InflaRx NV's investing sentiment can be driven by a variety of factors including economic data, InflaRx NV's earnings reports, geopolitical events, and overall market trends.

Comfort Level 55

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use InflaRx NV's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward InflaRx NV.

InflaRx Historical Sentiment

Although InflaRx NV's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding InflaRx, such as negative comments on social media and news outlets, may cause fear in the market and push InflaRx NV's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of InflaRx.
  

InflaRx NV Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards InflaRx NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

InflaRx NV Historical Investor Sentiment

Investor biases related to InflaRx NV's public news can be used to forecast risks associated with an investment in InflaRx. The trend in average sentiment can be used to explain how an investor holding InflaRx can time the market purely based on public headlines and social activities around InflaRx NV. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
InflaRx NV's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for InflaRx NV and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average InflaRx NV news discussions. The higher the estimate score, the more favorable the investor's outlook on InflaRx NV.
few days ago at news.google.com         
InflaRx Earns Buy Rating from HC Wainwright - Defense World
Google News at Macroaxis
six days ago at globenewswire.com         
InflaRx Showcases Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
Macroaxis News: globenewswire.com
six days ago at finance.yahoo.com         
InflaRx Showcases Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
Yahoo News
six days ago at gurufocus.com         
InflaRx Showcases Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
Gurufocus Stories at Macroaxis
over a week ago at globenewswire.com         
InflaRx to Showcase Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
Macroaxis News: globenewswire.com
over a week ago at finance.yahoo.com         
InflaRx to Showcase Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
Yahoo News
over a week ago at gurufocus.com         
InflaRx to Showcase Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March ...
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor C...
Yahoo News
over two weeks ago at news.google.com         
Short Interest in InflaRx Decreases By 13.7 percent - MarketBeat
Google News at Macroaxis
over three weeks ago at finance.yahoo.com         
InflaRx Announces Closing of 30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Yahoo News
over three weeks ago at gurufocus.com         
InflaRx Announces Closing of 30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Gurufocus Stories at Macroaxis
over three weeks ago at globenewswire.com         
InflaRx Announces Closing of 30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Macroaxis News: globenewswire.com
over three weeks ago at gurufocus.com         
InflaRx Announces Pricing of 30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Gurufocus Stories at Macroaxis
over three weeks ago at globenewswire.com         
InflaRx Announces Pricing of 30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about InflaRx NV that are available to investors today. That information is available publicly through InflaRx media outlets and privately through word of mouth or via InflaRx internal channels. However, regardless of the origin, that massive amount of InflaRx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InflaRx NV news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InflaRx NV relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InflaRx NV's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InflaRx NV alpha.

InflaRx NV Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
InflaRx Announces Participation in January Events in San Francisco
01/07/2025
2
InflaRx Receives European Commission Approval for GOHIBIC for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
01/15/2025
3
Short Interest in InflaRx Expands By 15.0 percent - MarketBeat
02/04/2025
4
InflaRx Announces Pricing of 30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
02/14/2025
5
InflaRx Announces Closing of 30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
02/18/2025
6
Short Interest in InflaRx Decreases By 13.7 percent - MarketBeat
02/20/2025
7
InflaRx to Showcase Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
02/28/2025
8
InflaRx Showcases Vilobelimabs Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
03/07/2025

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.